Big Health

San Francisco, CA · United States

Digital Health & DTxmid

Specialization: Prescription digital therapeutics for mental health

Key Differentiator

Holds FDA clearance for two prescription digital therapeutics, SleepioRx and DaylightRx.

Core Services

SleepioRx for chronic insomnia; DaylightRx for generalized anxiety disorder; Sleepio, Daylight and Spark Direct programs

Capabilities

FDA cleared prescription DTxDigital CBT for insomniaDigital therapy for anxietyRCT backed clinical evidence program

Market Intelligence

SleepioRx clearance was announced in August 2024. The company cites 22 completed RCTs and more than 100 peer-reviewed publications.

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.